GlassScriptPhysician profile
Dara K Winfield
NPI 1134463847
$1,878.34
in general payments reported to CMS, 2019-2025
15 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $274 · 2022: $410 · 2023: $553 · 2024: $347 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,194.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $507.38 | 2021-2023 | Epclusa, Sunlenca |
| Viiv Healthcare Company | $358.02 | 2021-2023 | Cabenuva |
| Abbvie INC. | $234.79 | 2022-2024 | |
| Dexcom, INC. | $203.60 | 2023-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Sanofi-Aventis U.S. LLC | $164.13 | 2024 | |
| Sage Therapeutics, LLC | $72.45 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $71.11 | 2025 | |
| Pfizer INC. | $70.82 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $45.66 | 2022-2025 | Gardasil 9, Capvaxive |
| Exact Sciences Corporation | $35.60 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Janssen Products, LP | $31.49 | 2021 | |
| Astellas Pharma US INC | $29.80 | 2025 | Veozah |
| Irhythm Technologies, INC. | $22.75 | 2024 | Zio Monitor, Zio Xt Patch |
| Alkermes, INC. | $16.48 | 2025 | Vivitrol |
| Axsome Therapeutics, INC. | $14.26 | 2024 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dara Winfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.